Grandem Syrup

About

Grandem Syrup contains Granisetron, a highly selective 5-HT3 receptor antagonist, which plays a crucial role in preventing and treating nausea and vomiting. Its therapeutic action involves blocking the effects of serotonin at the 5-HT3 receptors, which are predominantly found in the chemoreceptor trigger zone (CTZ) in the brain and on the vagal nerve terminals in the gastrointestinal tract. By inhibiting these receptors, Granisetron effectively interrupts the neural pathways that lead to the sensation of nausea and the act of vomiting.

This syrup formulation is particularly beneficial for pediatric patients and adults who have difficulty swallowing tablets, ensuring accurate and flexible dosing. It is widely used in clinical practice to manage emesis associated with highly emetogenic chemotherapy, radiation therapy, and post-operative recovery. The rapid absorption and consistent efficacy of Granisetron contribute significantly to improving patient comfort and compliance during challenging medical treatments.

Uses

• Prevention of chemotherapy-induced nausea and vomiting.
• Management of radiation-induced nausea and vomiting.
• Prevention of post-operative nausea and vomiting.
• Control of severe nausea and vomiting in various clinical settings.

Directions For Use

Administer the prescribed dose orally using a calibrated measuring spoon or cup. Follow your doctor's instructions carefully.

Benefits

• Effective in preventing and treating emesis.
• Convenient syrup form for easy administration.
• Suitable for pediatric and adult patients.
• Rapid absorption for prompt antiemetic action.
• Reduces discomfort and improves patient well-being.
• Targeted action with a favorable side effect profile.

Side Effects

• Headache
• Constipation
• Diarrhea
• Weakness (asthenia)
• Dizziness
• Insomnia
• Abdominal pain
• Fever
• Anxiety
• Rash
• Bradycardia
• Hypersensitivity reactions

Safety Measures

• Alcohol - It is advisable to avoid alcohol while taking this medication, as it may increase the risk of dizziness and gastrointestinal upset.
• Pregnancy - Use during pregnancy only if the potential benefits clearly outweigh the potential risks to the fetus. Consult your doctor for guidance.
• Breastfeeding - The excretion of Granisetron into human milk is unknown. Exercise caution and consult your doctor before breastfeeding.
• Liver - Patients with severe liver impairment should be monitored closely, and dose adjustments may be considered by the physician.
• Kidney - No specific dose adjustment is generally required for patients with renal impairment, but caution is advised in severe cases.
• Lung - Granisetron is generally safe for use in patients with pre-existing lung conditions; no specific pulmonary precautions are typically necessary.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.